Biofrontera (BFRI) Return on Invested Capital (2022 - 2025)

Biofrontera's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.11% for Q1 2025.

• On a quarterly basis, Return on Invested Capital fell 9.0% year-over-year to 0.11% in Q1 2025; TTM through Mar 2025 was 0.11%, a 9.0% decrease from a year earlier, with the FY2023 full-year figure at 0.04%, changed 0.0% from the prior year.
• Return on Invested Capital retreated to 0.11% in Q1 2025 per BFRI's latest filing, from 0.04% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q2 2023 and bottomed at 0.11% in Q1 2025.
• The 4-year median for Return on Invested Capital is 0.02% (2024), against an average of 0.04%.
• Across the five-year window, Return on Invested Capital gained 7 bps in 2023 and retreated 9 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 0.02% in 2022, then jumped by 32 bps to 0.02% in 2023, then slumped by 133 bps to 0.04% in 2024, then plunged by 196 bps to 0.11% in 2025.
• Per Business Quant, the three latest BFRI Return on Invested Capital figures stand at 0.11% (Q1 2025), 0.04% (Q4 2024), and 0.03% (Q3 2024).